USANA Health Sciences USNA Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation?
- USANA Health Sciences (USNA) reported cash provided by (used in) financing activity, including discontinued operation of -$3.64M in Q1 2026.
- How has USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation increased by 74.8% year-over-year, from -$14.47M to -$3.64M.
- What is the long-term trend for USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2021 to 2024), USANA Health Sciences's cash provided by (used in) financing activity, including discontinued operation has grown at a -62.5% compound annual growth rate (CAGR), from -$181.41M to $9.55M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.